To the best of our knowledge, this is the first study to investigate the prognostic potential of immunonutritional markers, including HALP, LMR, AISI, SIRS, and others for predicting postoperative extracranial complications in PD patients undergoing STN DBS. The gene discussed is NAT10; the disease is Parkinson disease.